Video index

1. Call to order and roll call

2. Consideration of January 21, 2022, draft meeting minutes

3. Open Meetings Act - refresher training for the board

4. Consideration of DURB Bylaws revision

5. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

6. Public comment on single new drugs to be reviewed for the Medicaid PDL

7. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

8. Executive work session

9. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

10. Retrospective drug utilization review (DUR): Conduent, LLC

11. Prospective prior authorization proposals (clinical edits): Kepro, LLC

12. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

13. Review of action items for next meeting: July 22, 2022, 9:00 a.m.

Apr 22, 2022 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order and roll call

2. Consideration of January 21, 2022, draft meeting minutes

3. Open Meetings Act - refresher training for the board

4. Consideration of DURB Bylaws revision

5. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

6. Public comment on single new drugs to be reviewed for the Medicaid PDL

7. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

8. Executive work session

9. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

10. Retrospective drug utilization review (DUR): Conduent, LLC

11. Prospective prior authorization proposals (clinical edits): Kepro, LLC

12. Retrospective drug use criteria for outpatient use in Vendor Drug Program: The University of Texas at Austin College of Pharmacy

13. Review of action items for next meeting: July 22, 2022, 9:00 a.m.

© 2003-2024 Swagit Productions, LLC